Madrigal Pharmaceuticals
The Madrigal story began in the early 2000s when founder Rebecca Taub, M.D., began applying her unique understanding of liver biology to explore therapies for MASH and metabolic disease.
Basic Information
- Category: Metabolic Diseases
- Founded: 2011
- Headquarters: West Conshohocken, PA
- Website: madrigalpharma.com
Documented Facts
- Email: info@madrigalpharma.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: MDGL (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Madrigal Pharmaceuticals — Official Site (official)
- Madrigal Pharmaceuticals on linkedin (social)
- MADRIGAL PHARMACEUTICALS, INC. — SEC EDGAR (reference)
Citation Guidance
Explore Metabolic Diseases profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Madrigal Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/madrigal-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/madrigal-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/madrigal-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:08.372Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
The Madrigal story began in the early 2000s when founder Rebecca Taub, M.D., began applying her unique understanding of liver biology to explore therapies for MASH and metabolic disease.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.